CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Current assets
Cash	$ 7,111	$ 9,375
Prepaid drug product for testing	377	376
Other current assets	862	902
Total current assets	8,350	10,653
Fixed assets
Furniture, fixtures & equipment	999	708
Less accumulated depreciation	(127)	(94)
Property, Plant and Equipment, Net	872	614
Other assets
Technology licenses	2,500	2,500
Less accumulated amortization	(1,611)	(1,571)
Intangible Assets, Net (Excluding Goodwill), Total	889	929
Total Assets	10,111	12,196
Current liabilities
Accounts payable	89	69
Accrued expense	608	969
Deferred revenue	12	12
Total current liabilities	709	1,050
Warrant liability	1,310	2,906
Total Liabilities	2,019	3,956
Shareholders' equity
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $.001 par value; 200,000 shares authorized; 95,645 and 95,645 shares issued and outstanding, respectively	96	96
Additional paid in capital	40,527	40,278
Accumulated deficit	(32,531)	(32,134)
Total shareholders' equity	8,092	8,240
Total Liabilities & Shareholders' Equity	$ 10,111	$ 12,196